Company profile of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

In 1992, the group company was only a medium-sized pharmaceutical enterprise in Hangzhou pharmaceutical system. After nearly six years of hard work, it has developed into a joint-stock enterprise-Huadong Pharmaceutical Co., Ltd. and several Sino-foreign joint ventures (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Hangzhou Moshadong Pharmaceutical Co., Ltd., Hangzhou Jiuyuan Genetic Engineering Co., Ltd., etc.) through introducing foreign capital, expanding scale, and complementing each other. The group company is good at seizing opportunities, and ranks among the "Top Ten Enterprise Groups in Hangzhou" and "18 Large Enterprise Groups specially cultivated by Zhejiang Provincial Government" with its advantages and development potential of high-tech pharmaceutical products, and is also listed among the 52 "National Key Enterprises" of the State Economic and Trade Commission.

since 25, the main economic indicators of the group as a whole have ranked first in Zhejiang pharmaceutical industry, and it is one of the 1 key large enterprises and enterprise groups cultivated by Hangzhou municipal government, and one of the 26 key large enterprise groups cultivated by Zhejiang provincial government, and it is one of the top 5 manufacturing enterprises in China.

From p>24 to 26, it was rated as one of the top ten outstanding industrial enterprises in Hangzhou for three consecutive years, and in 26 and 27.

Address of Beijing Company: No.83, Block A, Yuanda Center, Huizhong Road, Chaoyang District

Bus Rapid Transit 3 (Branch 3) Under Yanhuang Art Museum, under Exit A of Huixin West Street, Metro Line 5

Enterprise scale

Huadong Pharmaceutical Group has more than 2 member enterprises. There are mainly listed companies East China Pharmaceutical Co., Ltd., Hangzhou Zhongmei East China Pharmaceutical Co., Ltd., Hangzhou Jiuyuan Genetic Engineering Co., Ltd., Hangzhou Moshadong Pharmaceutical Co., Ltd., Zhejiang Huayi Pharmaceutical Co., Ltd., Esteve Huayi Pharmaceutical Co., Ltd., Hangzhou Zhuyangxin Pharmaceutical Co., Ltd., Hangzhou East China Pharmaceutical Group Kang Run Pharmaceutical Co., Ltd., etc. By the end of 28, there were more than 5, employees with total assets of 5.223 billion yuan. In 28, the sales revenue was 8.482 billion yuan, the total profit was 55 million yuan, and the total tax paid was 393 million yuan. It owns 31 patents, including 3 invention patents.